Skip to main content
Log in

Simultaneous Determination of the Purity and Potency of Vancomycin and Norvancomycin by HPLC

  • Full Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Vancomycin B and norvancomycin of chromatographic purity >99.0%, have been obtained by semi-preparative chromatography. Microbiological assays were used to measure the potency of the purified components, and the quantitative relationship between mass (mg) and potency (units) of pure vancomycin B and norvancomycin was determined. The values obtained were 1,123 units of vancomycin per milligram pure vancomycin B (C66H75Cl2N9O24), with fiducial limits of error (FL) from 1,105 to 1,144 units, and 1,025 units of norvancomycin per milligram pure norvancomycin (C65H72Cl2N9O24), with FL from 1,011 to 1,039 units. The potency (units mg−1) of the main active component of house reference standards of vancomycin and norvancomycin could be determined by HPLC. Thus, in routine quality control, potency and purity could be assayed simultaneously by use of HPLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Thomas AH (1987) J Pharm Biomed Anal 5:319–324

    Article  CAS  Google Scholar 

  2. Vanderhaeghe H (1989) J Pharm Biomed Anal 7:127–128

    Article  CAS  Google Scholar 

  3. Hoogmartens J (1992) J Pharm Biomed Anal 10:845–850

    Article  CAS  Google Scholar 

  4. Lighbrown JW, de Rossi P, Isaacson P (1972) Bull World Health Organ 47:343–356

    Google Scholar 

  5. Ling DQ, Zhou Y, Chen S (1986) Acta Pharm Sin 21:208–212

    CAS  Google Scholar 

  6. Inman EL (1987) J Chromatogr 410:363–372

    Article  CAS  Google Scholar 

  7. Liu M, Hu CQ (2003) J Chin Pharm Univ 34:347–351

    CAS  Google Scholar 

  8. United States Pharmacopeial Convention (2002) In: United States Pharmacopoeia XXV. The United States Pharmacopeial Convention, Rockville, pp 1793–1795

  9. British Pharmacopoeia Commission Office (2005) In: British Pharmacopoeia 2005. The Stationary Office, London, pp 205–2053

  10. European Pharmacopoeia Commission (2004) In: European Pharmacopoeia, 5th edn. Council of Europe, Strasbourg, pp 267–2672

  11. The State Pharmacopoeia Commission of PR China (2000) Pharmacopoeia of the People’s Republic of China Edition. Chemical Industry Press, Beijing, pp 55–555

  12. The State Pharmacopoeia Commission of PR China (2005) Pharmacopoeia of the People’s Republic of China Edition, Chemical Industry Press, Beijing, pp 467–469

  13. Healy VL, Lessard IAD, Roper DI, Knox JR, Walsh CT (2000) Chem Biol 7:R109–R119

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the North China Pharmaceutical Factory (Shijiazhuang, China), and Eli Lilly and Company (Eli Lilly Asia, Inc., Beijing, Rep. Office).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Changqin Hu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, M., Hu, C. Simultaneous Determination of the Purity and Potency of Vancomycin and Norvancomycin by HPLC. Chroma 65, 203–207 (2007). https://doi.org/10.1365/s10337-006-0134-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-006-0134-1

Keywords

Navigation